Free shipping on all orders over $ 500

GW274150 

Cat. No. M56380

All AbMole products are for research use only, cannot be used for human consumption.

GW274150  Structure
Size Price Availability Quantity
5mg USD 95  USD95 In stock
10mg USD 158  USD158 In stock
25mg USD 325  USD325 In stock
50mg USD 525  USD525 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

GW274150 is a potent, selective, orally active and NADPH-dependent inhibitor of human inducible nitric oxide synthase (iNOS) (IC50=2.19 μM; Kd=40 nM) and rat iNOS (ED50=1.15 μM).

Chemical Information
Molecular Weight 219.3
Formula C8H17N3O2S
CAS Number 210354-22-6
Form Solid
Solubility (25°C) DMSO 100 mg/mL
Water ≥ 62 mg/mL
Storage 4°C, sealed
Related NO Synthase Products
FeTPPS

FeTPPS acts as a peroxynitrite scavenger and anti-nitrating agent in vivo. FeTPPS reduces nitric oxide (NO) production and apoptosis process. FeTPPS possesses evident neuroprotective effects in a experimental model of spinal cord damage.

(S)-ZLc002 

(S)-ZLc002 is a S-enantiomer of ZLc-002.

NOS-IN-1 

NOS-IN-1 is a potent and orally active NO synthase (NOS) isoforms inhibitor with IC50s of 0.1 μM, 1.1 μM, and 0.2 μM for human iNOS (hiNOS), heNOS and hnNOS, respectively.

ARL 17477 

ARL-17477 is a dual inhibitor of NOS1and the autophagy-lysosomal system with anticancer activity and can inhibit tumor growth in KRAS-mutated cancers.

NOS1-IN-1 

NOS1-IN-1 is a selective and cell-permeable nNOS inhibitor with a Ki of 120 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: GW274150  supplier, NO Synthase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.